Skip to content

Evaluating the effect of an intelligent surveillance system on the surveillance rate of patients with gastric low grade intraepithelial neoplasia

Effect of an intelligent surveillance system on the surveillance rate of patients with gastric precancerous conditions and lesions

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062204
Enrollment
Unknown
Registered
2022-07-29
Start date
2022-07-29
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric low grade intraepithelial neoplasia

Interventions

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged >=18 years who underwent endoscopic examination and were pathologically diagnosed with gastric intraepithelial neoplasia.

Exclusion criteria

Exclusion criteria: 1. History of gastrointestinal malignancy; 2. Previous history of gastric surgery or ESD surgery; 3. No contact information or invalid contact information; 4. Have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials; 5. Drug or alcohol abuse or psychological disorder in the last 5 years; 6. Pregnant or lactating patients; 7. The investigator believes that the patient is not suitable for gastroscopy and related examinations; 8. High-risk diseases or other special conditions for which the patient is deemed unsuitable for clinical trials by the investigator.

Design outcomes

Primary

MeasureTime frame
surveillance rate;

Secondary

MeasureTime frame
the rate of surveillance in advance;the rate of surveillance on time;the rate of delayed surveillance;the accuracy of the system on classifying risk levels;the accuracy of the system on assigning surveillance intervals;the accuracy of the system on identifying patients;the rate of lesion progression;the rate of lesion persistence;the rate of lesion regression;the incidence of early gastric cancer;the incidence of gastric cancer;the detection rate of early gastric cancer;

Countries

China

Contacts

Public ContactYu Honggang

Renmin Hospital of Wuhan University

yuhonggang1968@163.com+86 13971281899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026